Literature DB >> 31858336

A retrospective study of bone scintigraphy in the follow-up of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: is it useful to repeat bone scintigraphy for disease assessment?

Chen Li1, Lun Wang2, Nan Wu3,4,5, Yihan Cao6, Xiaochuan Sun7, Wen Zhang7, Hongli Jing8.   

Abstract

OBJECTIVES: To investigate the value of repeated bone scintigraphy in the follow-up of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome and to characterize the changing pattern of osteoarticular lesions revealed by bone scintigraphy.
METHOD: Twenty-four patients with SAPHO syndrome who had repetitively undergone bone scintigraphy and tests of inflammatory markers (erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP)) were included in this retrospective study. The change in accumulation number was recorded as the difference in the number of accumulation sites between consecutive bone scintigraphy. The visual analog scale (VAS) for pain and medications prescribed were also reviewed. The relationships of the change in accumulation number with medication prescribed and change in ESR or CRP were analyzed.
RESULTS: Twenty-four and 23 patients had follow-up tests of ESR and CRP, from which 30 and 28 follow-up data were obtained, containing the corresponding changes in ESR and CRP, respectively. A decrease in total accumulation number observed by bone scintigraphy was rarely observed, while decreases in ESR, CRP, and VAS were predominant. The accumulation number had significantly increased over time (follow-up with ESR: r = 0.389, p = 0.034; follow-up with CRP: r = 0.438, p = 0.020), in accordance with an "imprinting" pattern, while the inflammatory markers and VAS for pain predominantly decreased. There was no significant association between the change in accumulation number (local/total) and the change in ESR or CRP values (p > 0.05) or medications used for SAPHO (p > 0.05).
CONCLUSIONS: This retrospective cohort study of 24 SAPHO patients demonstrated an "imprinting" pattern on bone scintigraphy, without a correlation to the decrease in inflammatory markers, patient disease assessment, or treatment type. Thus, repeated bone scintigraphy did not contribute an additional clinical value for the follow-up of patients with SAPHO.Key Points• In a cohort of 24 SAPHO patients, repeated bone scintigraphy revealed a continuous increase in tracer accumulation number, indicating an "imprinting" pattern.• The change in tracer accumulation number, defined as the difference in the number of accumulation sites between consecutive bone scintigraphy measurements, was inconsistent with the change in ESR, CRP, or VAS for pain.• The medications prescribed for SAPHO did not seem to contribute to a decrease in accumulation number.• Repeated bone scintigraphy did not seem to be useful for the assessment of disease activity in patients with SAPHO.

Entities:  

Keywords:  Bone scintigraphy; C-reactive protein; Erythrocyte sedimentation rate; Follow-up; SAPHO syndrome; Treatment

Year:  2019        PMID: 31858336     DOI: 10.1007/s10067-019-04864-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

Review 1.  SAPHO: What radiologists should know.

Authors:  R Depasquale; N Kumar; R K Lalam; B J Tins; P N M Tyrrell; J Singh; V N Cassar-Pullicino
Journal:  Clin Radiol       Date:  2011-09-21       Impact factor: 2.350

2.  Spinal and sacroiliac involvement in SAPHO syndrome: A single center study of a cohort of 354 patients.

Authors:  Yihan Cao; Chen Li; Wenrui Xu; Xia Wu; Xiaochuan Sun; Weihong Zhang; Hongli Jing; Zhaoqi Gu; Siyi Yuan; Li Li; Yuzhi Zuo; Jinhe Liu; Zhihong Wu; Zhenhua Dong; Weixin Hao; Wen Zhang; Nan Wu
Journal:  Semin Arthritis Rheum       Date:  2018-09-29       Impact factor: 5.532

3.  Three patterns of osteoarticular involvement in SAPHO syndrome: a cluster analysis based on whole body bone scintigraphy of 157 patients.

Authors:  Yihan Cao; Chen Li; Qiao Yang; Nan Wu; Ping Xu; Yueting Li; Ximin Shi; Qingqing Pan; Xia Wu; Xiaochuan Sun; Yanxue Zhao; Zhaoqi Gu; Siyi Yuan; Yuzhi Zuo; Li Li; Weihong Zhang; Weixin Hao; Jinhe Liu; Hongli Jing; Wen Zhang
Journal:  Rheumatology (Oxford)       Date:  2019-06-01       Impact factor: 7.580

Review 4.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 5.  Imaging Scoring Methods in Axial Spondyloarthritis.

Authors:  Xenofon Baraliakos; Juergen Braun
Journal:  Rheum Dis Clin North Am       Date:  2016-11       Impact factor: 2.670

6.  Bone scintigraphy in axial seronegative spondyloarthritis patients: role in detection of subclinical peripheral arthritis and disease activity.

Authors:  Tamer A Gheita; Ghada S Azkalany; Sanaa A Kenawy; Ahmed A Kandeel
Journal:  Int J Rheum Dis       Date:  2014-12-20       Impact factor: 2.454

Review 7.  Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment.

Authors:  Francesco Cianci; Angelo Zoli; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Clin Rheumatol       Date:  2017-07-19       Impact factor: 2.980

8.  [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases].

Authors:  A M Chamot; C L Benhamou; M F Kahn; L Beraneck; G Kaplan; A Prost
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-03

9.  F-18 FDG PET/CT in 26 patients with SAPHO syndrome: a new vision of clinical and bone scintigraphy correlation.

Authors:  Xiaochuan Sun; Chen Li; Yihan Cao; Ximin Shi; Li Li; Weihong Zhang; Xia Wu; Nan Wu; Hongli Jing; Wen Zhang
Journal:  J Orthop Surg Res       Date:  2018-05-22       Impact factor: 2.359

10.  The EANM practice guidelines for bone scintigraphy.

Authors:  T Van den Wyngaert; K Strobel; W U Kampen; T Kuwert; W van der Bruggen; H K Mohan; G Gnanasegaran; R Delgado-Bolton; W A Weber; M Beheshti; W Langsteger; F Giammarile; F M Mottaghy; F Paycha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.